Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Thoracic 2 Other solid neoplasm 1 Genitourinary 1 Gastrointestinal 1

Conditions

Mesothelioma, Malignant 1

Interventions

Injections 17 Cisplatin 15 Carboplatin 15 Oxaliplatin 11 Gemcitabine 11 pembrolizumab 8 Capecitabine 8 toripalimab 7 Paclitaxel 7 Etoposide 7 Cyclophosphamide 7 Pemetrexed 6 Irinotecan 6 Drug Therapy 6 spartalizumab 5 fludarabine 5 camrelizumab 5 Vincristine 5 Radiotherapy 5 Leucovorin 5 tislelizumab 4 apatinib 4 anlotinib 4 Interleukin-2 4 Immune Checkpoint Inhibitors 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Fluorouracil 4 Docetaxel 4 Bevacizumab 4 tremelimumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × talazoparib × Other solid neoplasm × Clear all

NCT04462809 2020-07-09

TALAMESO

Hospices Civils de Lyon

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡